The response of circulating levels of the interleukin-6/interleukin-6 receptor complex to exercise in young men

Cytokine

Volumn 47, Issue 2, 2009, Pages 98-102

  Gray, S R ^a   Clifford, M ^a   Lancaster, R ^a   Leggate, M ^a   Davies, M ^b   Nimmo, M A ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cycling; Cytokines; Exercise; Interleukin 6; Trans signalling

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; COMPLEX FORMATION; CYCLING; EXERCISE; GLUCOSE METABOLISM; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLASMA VOLUME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; EXERCISE; HUMANS; INTERLEUKIN-6; MALE; RECEPTORS, INTERLEUKIN-6;

EID: 67650578602     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.05.011     Document Type: Article

References (50)

1. Akira S., Taga T., and Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 54 (1993) 1-78
2. Bastard J.P., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87 (2002) 2084-2089
3. Bauer J., Lengyel G., Bauer T.M., Acs G., and Gerok W. Regulation of interleukin-6 receptor expression in human monocytes and hepatocytes. FEBS Lett 249 (1989) 27-30
4. Beaver W.L., Wasserman K., and Whipp B.J. Improved detection of lactate threshold during exercise using a log-log transformation. J Appl Physiol 59 (1985) 1936-1940
5. Dill D.B., and Costill D.L. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37 (1974) 247-248
6. Febbraio M.A., Hiscock N., Sacchetti M., Fischer C.P., and Pedersen B.K. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53 (2004) 1643-1648
7. Febbraio M.A., and Pedersen B.K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16 (2002) 1335-1347
8. Febbraio M.A., Steensberg A., Keller C., Starkie R.L., Nielsen H.B., Krustrup P., et al. Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. J Physiol (Lond) 549 (2003) 607-612
9. Gaillard J.P., Liautard J., Mani J.C., Fernandez Suarez J.M., Klein B., and Brochier J. Identification of a novel antigenic structure of the human receptor for interleukin-6 involved in the interaction with the glycoprotein 130 chain. Immunology 89 (1996) 135-141
10. Gray S.R., Robinson M., and Nimmo M.A. Response of plasma IL-6 and its soluble receptors during submaximal exercise to fatigue in sedentary middle-aged men. Cell Stress Chaperones 13 (2008) 247-251
11. Hiscock N., Fischer C.P., Sacchetti M., van Hall G., Febbraio M.A., and Pedersen B.K. Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans. Am J Physiol Endocrinol Metab 289 (2005) E2-E7
12. Honda M., Yamamoto S., Cheng M., Yasukawa K., Suzuki H., Saito T., et al. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 148 (1992) 2175-2180
13. Jones S.A. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175 (2005) 3463-3468
14. Jones S.A., Richards P.J., Scheller J., and Rose-John S. IL-6 transsignaling: the in vivo consequences. J Interferon Cytokine Res 25 (2005) 241-253
15. Jostock T., Mullberg J., Ozbek S., Atreya R., Blinn G., Voltz N., et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 268 (2001) 160-167
16. Kado S., Nagase T., and Nagata N. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetol 36 (1999) 67-72
17. Keller C., Steensberg A., Hansen A.K., Fischer C.P., Plomgaard P., and Pedersen B.K. Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol 99 (2005) 2075-2079
18. Keller C., Steensberg A., Pilegaard H., Osada T., Saltin B., Pedersen B.K., et al. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 15 (2001) 2748-2750
19. Keller P., Keller C., Carey A.L., Jauffred S., Fischer C.P., Steensberg A., et al. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem Biophys Res commun 310 (2003) 550-554
20. Keller P., Penkowa M., Keller C., Steensberg A., Fischer C.P., Giralt M., et al. Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J 19 (2005) 1181-1183
21. Kishimoto T., Akira S., Narazaki M., and Taga T. Interleukin-6 family of cytokines and gp130. Blood 86 (1995) 1243-1254
22. Maes M., Libbrecht I., Van Hunsel F., Lin A.H., De Clerck L., Stevens W., et al. The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. Psychoneuroendocrinology 24 (1999) 371-383
23. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260 (1993) 1808-1810
24. Nieman D.C., Davis J.M., Henson D.A., Walberg-Rankin J., Shute M., Dumke C.L., et al. Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J Appl Physiol 94 (2003) 1917-1925
25. Northoff H., and Berg A. Immunologic mediators as parameters of the reaction to strenuous exercise. Int J Sports Med 12 Suppl. 1 (1991) S9-S15
26. Nowell M.A., Richards P.J., Horiuchi S., Yamamoto N., Rose-John S., Topley N., et al. Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J Immunol 171 (2003) 3202-3209
27. Ostrowski K., Hermann C., Bangash A., Schjerling P., Nielsen J.N., and Pedersen B.K. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol (Lond) 513 (1998) 889-894
28. Patterson S., Reid S., Gray S., and Nimmo M. The response of plasma interleukin-6 and its soluble receptors to exercise in the cold in humans. J Sports Sci 26 (2008) 927-933
29. Pedersen B.K. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 42 (2006) 105-117
30. Penkowa M., Keller C., Keller P., Jauffred S., and Pedersen B.K. Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J 17 (2003) 2166-2168
31. Peters M., Jacobs S., Ehlers M., Vollmer P., Mullberg J., Wolf E., et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med 183 (1996) 1399-1406
32. Petersen A.M., and Pedersen B.K. The anti-inflammatory effect of exercise. J Appl Physiol 98 (2005) 1154-1162
33. Petersen E.W., Carey A.L., Sacchetti M., Steinberg G.R., Macaulay S.L., Febbraio M.A., et al. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol Endocrinol Metab 288 (2005) E155-E162
34. Pignatti P., Ciapponi L., Galle P., Hansen M.B., Massa M., Meazza C., et al. High circulating levels of biologically inactive IL-6/sIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130. Clin Exp Immunol 131 (2003) 355-363
35. Polgar A., Brozik M., Toth S., Holub M., Hegyi K., Kadar A., et al. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis. Med Sci Monit 6 (2000) 13-18
36. Robak T., Gladalska A., Stepien H., and Robak E. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis. Mediators Inflamm 7 (1998) 347-353
37. Robson-Ansley P., Barwood M., Canavan J., Hack S., Eglin C., Davey S., et al. The effect of repeated endurance exercise on IL-6 and sIL-6R and their relationship with sensations of fatigue at rest. Cytokine 45 (2009) 111-116
38. Robson-Ansley P.J., Milander L., Collins M., and Noakes T.D. Acute interleukin-6 infusion impairs athletic performance in healthy, trained male runners. Can J Appl Physiol 29 (2004) 411-418
39. Rose-John S. Coordination of interleukin-6 biology by membrane bound and soluble receptors. Adv Exp Med Biol 495 (2001) 145-151
40. Rose-John S. Interleukin-6 biology is coordinated by membrane bound and soluble receptors. Acta Biochim Pol 50 (2003) 603-611
41. Rose-John S., and Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300 Pt. 2 (1994) 281-290
42. Scheller J., Ohnesorge N., and Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol 63 (2006) 321-329
43. Schobitz B., de Kloet E.R., Sutanto W., and Holsboer F. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci 5 (1993) 1426-1435
44. Schobitz B., Pezeshki G., Pohl T., Hemmann U., Heinrich P.C., Holsboer F., et al. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J 9 (1995) 659-664
45. Somers W., Stahl M., and Seehra J.S. 1.9 Å crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J 16 (1997) 989-997
46. Steensberg A., Fischer C.P., Keller C., Moller K., and Pedersen B.K. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285 (2003) E433-E437
47. Steensberg A., van Hall G., Osada T., Sacchetti M., Saltin B., and Pedersen B.K. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol (Lond) 529 (2000) 237-242
48. Taga T., and Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15 (1997) 797-819
49. van Hall G., Steensberg A., Sacchetti M., Fischer C., Keller C., Schjerling P., et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88 (2003) 3005-3010
50. Ward L.D., Howlett G.J., Discolo G., Yasukawa K., Hammacher A., Moritz R.L., et al. High affinity Interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor and gp130. J Biol Chem 269 (1994) 23286-23289